|
TBC1D19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02160000015061E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.81080000000367E-07 |
| Normal-vs-Stage2 |
1.578110E-03 |
| Normal-vs-Stage3 |
1.358020E-03 |
| Normal-vs-Stage4 |
3.817300E-04 |
| Stage1-vs-Stage2 |
6.057000E-01 |
| Stage1-vs-Stage3 |
7.304200E-01 |
| Stage1-vs-Stage4 |
5.623000E-01 |
| Stage2-vs-Stage3 |
5.356600E-01 |
| Stage2-vs-Stage4 |
3.427800E-01 |
| Stage3-vs-Stage4 |
7.927000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.16189999960415E-07 |
| Normal-vs-AfricanAmerican |
1.76050000000316E-06 |
| Normal-vs-Asian |
4.238100E-04 |
| Caucasian-vs-AfricanAmerican |
7.298200E-01 |
| Caucasian-vs-Asian |
2.443800E-01 |
| AfricanAmerican-vs-Asian |
2.255800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38089999990321E-07 |
| Normal-vs-Female |
2.823000E-04 |
| Male-vs-Female |
1.644770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.80450000000421E-05 |
| Normal-vs-Extreme_Weight |
2.98350000260683E-08 |
| Normal-vs-Obese |
1.242590E-04 |
| Normal-vs-Extreme_Obese |
1.343760E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.213400E-01 |
| Normal_Weight-vs-Obese |
4.362200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.773200E-01 |
| Extreme_Weight-vs-Obese |
1.256640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.346400E-01 |
| Obese-vs-Extreme_Obese |
7.424400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.41899999978246E-07 |
| Normal-vs-Age(41-60Yrs) |
1.7578699999965E-05 |
| Normal-vs-Age(61-80Yrs) |
5.83370000084571E-08 |
| Normal-vs-Age(81-100Yrs) |
3.582200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.429900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.976840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.650050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.234010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.653200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.153400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.73820000018921E-07 |
| Normal-VS-Type2 PRCC |
4.20150000000064E-05 |
| Normal-VS-KIRP CIMP |
8.94399998507822E-09 |
| Normal-VS-Unclassified PRCC |
9.123500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.867400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.635300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.151370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.842300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.697200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.401800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.00799999997103E-06 |
| Normal-vs-N1 |
3.538000E-03 |
| Normal-vs-N2 |
9.224100E-04 |
| N0-vs-N1 |
9.353800E-01 |
| N0-vs-N2 |
4.444000E-01 |
| N1-vs-N2 |
3.169000E-01 |
|
|
